COMP <GO>
CTOR vs HRTX // NET PROFIT MARGIN
Citius Oncology Inc. (NASDAQ) VS. Heron Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: CTOR 0
— HRTX 3
■ METRIC PARITY
LAST: $0.59 (+7.24%) • MKT CAP: $55.2M
net-margins
—
LAST: $0.30 (+6.27%) • MKT CAP: $56.0M
net-margins
-12.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CTOR VS. HRTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CTOR | HRTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 73.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -11.16% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -1.60% | — | TIE | /operating-margins <GO> |
| Net Profit Margin ACTIVE | — | -12.90% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 2/9 | -1.00 | HRTX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.1 | 43.7 | -6.60 | HRTX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $55.2M | $56.0M | -$785.3K | HRTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CTOR REV | HRTX REV | CTOR GROSS % | HRTX GROSS % | CTOR FCF | HRTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $65.9M | $154.9M | — | 73.3% | -$5.5M | -$27.9M |
| FY 2024 | $57.6M | $144.3M | — | 73.2% | $126.4K | -$24.2M |
| FY 2023 | $2.8M | $309.7M | — | — | -$601.3K | -$58.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CTOR // BETA —
HRTX // BETA —